Lilly partners with Nvidia to build supercomputer for drug R&D
Eli Lilly is partnering with Nvidia to build “the most powerful supercomputer owned and operated by a pharmaceutical company” to help discover new medicines.
The drugmaker announced the deal on Tuesday, following a slew of deals Nvidia announced with other companies. Lilly did not specify the terms of the deal but did say it is using 1,000 Nvidia GPUs.
Lilly — the maker of the blockbuster diabetes and weight-loss shots Mounjaro and Zepbound — said the supercomputer “will help scientists identify, optimize and validate new molecules.”
“With purpose-built AI models and AI, we can set a new scientific standard that accelerates innovation to deliver medicines to more patients, faster,” Diogo Rau, Lilly’s chief information and digital officer, said in a statement.